How does thymus infection by coxsackievirus contribute to the pathogenesis of type 1 diabetes?

Frontiers in Immunology

Volumn 6, Issue JUN, 2015, Pages

  Michaux, Hélène ^a   Martens, Henri ^a   Jaïdane, Hela ^b,c   Halouani, Aymen ^b,c   Hober, Didier ^d   Geenen, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Coxsackievirus; Enterovirus; Insulin family; Insulin like growth factor 2; Self tolerance; Thymus; Type 1 diabetes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 6; SOMATOMEDIN B;

CELL DIFFERENTIATION; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS B4; FOOD ALLERGY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR PATHOLOGY; NONHUMAN; PANCREAS ISLET BETA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT SURVEY; T LYMPHOCYTE; THYMUS DISEASE;

EID: 84935139810     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00338     Document Type: Short Survey

References (62)

1. Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem (2011) 57:176-85. doi:10.1373/clinchem.2010.148221
2. Hyöti H, Hiltunen M, Knip M, Laakonen M, Vähäsalo P, Karjalainen J, et al. A prospective role of coxsackie B and enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes (1995) 44:652-67. doi:10.2337/diabetes.44.6.652
3. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ (2011) 342:d35. doi:10.1136/bmj.d35
4. Oikarinen S, Tauriainen S, Hober D, Lucas B, Vazeou A, Sioofy-Khojine A, et al. VirDiab Study Group. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes (2014) 63:655-62. doi:10.2337/db13-0620
5. Jaïdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab (2008) 34:537-48. doi:10.1016/j.diabet.2008.05.008
6. Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol (2010) 6:279-89. doi:10.1038/nrendo.2010.27
7. Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol (2010) 20:265-80. doi:10.1002/rmv.647
8. Chehadeh W, Weill J, Vantyghem MC, Alm G, Lefebvre J, Wattré P, et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackie B virus infection. J Infect Dis (2000) 181:1929-39. doi:10.1086/315516
9. Chehadeh W, Kerr-Conte J, Patou F, Alm G, Lefebvre J, Wattré P, et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha-interferon synthesis in beta cells. J Virol (2000) 74:10153-64. doi:10.1128/JVI.74.21.10153-10164.2000
10. Yin H, Berg AK, Westman J, Hellerström C, Frisk G. Complete nucleotide sequence of a coxsackievirus B4 strain capable of establishing persistent infection in human pancreatic islets: effects on insulin release, proinsulin synthesis, and cell morphology. J Med Virol (2002) 68:544-7. doi:10.1002/jmv.10236
11. Roivanen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab (2000) 85:432-40. doi:10.1210/jc.85.1.432
12. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest (2002) 109:79-87. doi:10.1172/JCI0211198
13. Dotta F, Censini S, van Halteren AGS, Marselli L, Masini M, Dionisi S, et al. Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A (2007) 104:5115-20. doi:10.1073/pnas.0700442104
14. Alidjinou EK, Sané F, Engelmann I, Geenen V, Hober D. Enterovrus persistence as a mechanism in the pathogenesis of type 1 diabetes. Discov Med (2014) 18:273-82.
15. Krogvold L, Bjorn E, Buanes T, Frisk G, Skog O, Anagandula M, et al. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes (2015) 64:1682-7. doi:10.2337/db14-1370
16. Field LL, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen TB, Beck-Nielsen H. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes (2005) 54:1588-91. doi:10.2337/diabetes.54.5.1588
17. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, et al. A genome-vide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet (2006) 38:617-9. doi:10.1038/ng1800
18. Bonomo A, Matzinger P. Thymus epithelium induces tissue-specific tolerance. J Exp Med (1993) 177:1153-64. doi:10.1084/jem.177.4.1153
19. Martens H, Goxe B, Geenen V. The thymic repertoire of neuroendocrine self-antigens: physiological implications in T-cell life and death. Immunol Today (1996) 17:312-7. doi:10.1016/0167-5699(96)10023-2
20. Geenen V, Bodart G, Henry S, Michaux H, Dardenne O, Charlet-Renard C, et al. Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity. Front Neurosci (2013) 7:187. doi:10.3389/fnins.2013.00187
21. Kyewski B, Klein L. The central role of central tolerance. Annu Rev Immunol (2006) 24:571-605. doi:10.1146/annurev.immunol.23.021704.115601
22. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzin SP, Turley SJ, et al. Projection of an immunological self shadow in the thymus by the Aire protein. Science (2002) 298:1395-401. doi:10.1126/science.1075958
23. Ucar O, Rattay K. Promiscuous gene expression in the thymus: a matter of epigenetics, miRNA and more? Front Immunol (2015) 6:93. doi:10.3389/fimmu.2015.00093
24. Like AA, Kislaukis E, Williams RM, Rossini AA. Neonatal thymectomy prevents spontaneous diabetes in the BB:W rat. Science (1982) 216:644-6. doi:10.1126/science.7041259
25. Georgiou HM, Bellgrau D. Induction of insulitis in athymic (nude) mice. The effect of NOD thymus and pancreas transplantation. Diabetes (1995) 44:49-59. doi:10.2337/diabetes.44.1.49
26. Thomas-Vaslin V, Damotte D, Coltey M, Le Douarin NM, Coutinho A, Salaün J. Abnormal T cell selection on nod thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice. Proc Natl Acad Sci U S A (1997) 94:4598-603. doi:10.1073/pnas.94.9.4598
27. Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol (2001) 2:1025-31. doi:10.1038/ni726
28. Zucchelli S, Holler P, Yamagata T, Roy M, Benoist C, Mathis D. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity (2005) 22:385-96. doi:10.1016/j.immuni.2005.01.015
29. Mingueneau M, Jiand W, Feuerer M, Mathis D, Benoist C. Thymic negative selection is functional in NOD mice. J Exp Med (2012) 209:623-37. doi:10.1084/jem.20112593
30. Kecha-Kamoun O, Achour I, Martens H, Collette J, Lefebvre PJ, Greiner DL, et al. Thymic expression of insulin-related genes in an animal of type 1 diabetes. Diabetes Metab Res Rev (2001) 17:146-52. doi:10.1002/dmmr.182
31. Vafiadis P, Bennett ST, Todd JA, Nadeau J, Grabs R, Goodyer CG, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet (1997) 15:289-92. doi:10.1038/ng0397-289
32. Pugliese A, Zeller M, Fernandez A Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 15:293-7. doi:10.1038/ng0397-293
33. Sabater L, Ferrer-Francesch X, Sospedra M, Caro P, Juan M, Pujol-Borrell R. Insulin alleles and autoimmune regulator (AIRE) gene both influence insulin expression in the thymus. J Autoimmun (2005) 25:312-8. doi:10.1016/j.aut.2005.08.006
34. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient mice. J Clin Invest (2003) 111:851-7. doi:10.1172/JCI16584
35. Moriyama H, Abiru N, Paronen J, Sikora K, Liu E, Miao D, et al. Evidence for a primary islet autoantigen (proinsulin 1) for insulitis and diabetes in the nonobese diabetic mice. Proc Natl Acad Sci U S A (2003) 100:10376-81. doi:10.1073/pnas.1834450100
36. Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature (2005) 435:220-3. doi:10.1038/nature03523
37. Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature (2005) 435:224-8. doi:10.1038/nature03625
38. Fan Y, Rudert WA, Grupillo M, He J, Sisino G, Trucco M. Thymus-specific deletion of insulin induces autoimmune diabetes. EMBO J (2009) 28:2812-24. doi:10.1038/emboj.2009.212
39. Noso S, Kataoka K, Kawabata Y, Babaya N, Hiromine Y, Yamaji K, et al. Insulin transactivator MafA regulates intrathymic transcription of insulin and affects susceptibility to type 1 diabetes. Diabetes (2010) 59:2579-87. doi:10.2337/db10-0476
40. Ashton-Rickardt P, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell (1994) 76:651-63. doi:10.1016/0092-8674(94)90505-3
41. Kanatsuma N, Taneera J, Vaziri-Sani F, Wierup N, Larsson HE, Delli A, et al. Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets. J Biol Chem (2013) 288:29013-23. doi:10.1074/jbc.M113.478222
42. Hansenne I, Charlet-Renard C, Greimers R, Geenen V. Dendritic cell differentiation and tolerance to insulin-related peptides in Igf2-deficient mice. J Immunol (2006) 176:4651-7. doi:10.4049/jimmunol.176.8.4651
43. Geenen V, Louis C, Martens H. The Belgian diabetes registry. An insulin-like growth factor 2-derived self-antigen inducing a regulatory cytokine profile to peripheral blood mononuclear cells from DQ8+ type 1 diabetic adolescents: preliminary design of a thymus-based tolerogenic self-vaccination. Ann N Y Acad Sci (2004) 1037:59-64. doi:10.1196/annals.1337.008
44. Yang G, Geng XR, Song JP, Wu Y, Yan H, Zhan Z, et al. Insulin-like growth factor 2 enhances regulatory T-cell functions and suppresses food allergy in an experimental model. J Allergy ClinImmunol (2014) 133:1702-8. doi:10.1016/j.jaci.2014.02.019
45. Geng XR, Yang G, Li M, Song JP, Liu ZQ, Qiu S, et al. Insulin-like growth factor 2 enhances functions of antigen (Ag)-specific regulatory B cells. J Biol Chem (2014) 289:17941-50. doi:10.1074/jbc.M113.515262
46. Kecha O, Brilot F, Martens H, Franchimont N, Renard C, Greimers R, et al. Involvement of insulin-like growth factors in early T cell development: a study using fetal thymic organ cultures. Endocrinology (2000) 141:1209-17. doi:10.210/en.141.3.1209
47. Pfister K, Forster F, Paster W, Supper V, Ohradanova-Repic A, Eckerstorfer P, et al. The late endosomal transporter CD222 directs the spatial distribution and activity of Lck. J Immunol (2014) 193:2718-32. doi:10.4049/jimmunol.1303349
48. Geenen V, Mottet M, Dardenne O, Kermani H, Martens H, Francois JM, et al. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes. Curr Opin Pharmacol (2010) 10:461-72. doi:10.1016/j.coph.2010.04.005
49. Brilot F, Chehadeh W, Charlet-Renard C, Martens H, Geenen V, Hober D. Persistent infection of human thymic epithelial cells by coxsackievirus B4. J Virol (2002) 76:5260-5. doi:10.1128/JVI.76.10.5260-5265.2002
50. Shih FF, Mandik-Nayak L, Wipke BT, Allen PM. Massive thymic deletion results in systemic autoimmunity through elimination of CD4+CD25+ T regulatory cells. J Exp Med (2004) 199:323-35. doi:10.1084/jem.20031137
51. Brilot F, Geenen V, Hober D, Stoddart C. Coxsackievirus B4 infection of human fetal thymus cells. J Virol (2004) 78:9854-61. doi:10.1128/JVI.78.18.9854-9861.2004
52. Brilot F, Jaïdane H, Geenen V, Hober D. Coxsackievirus B4 infection of murine fetal thymus organ cultures. J Med Virol (2008) 80:659-66. doi:10.1002/jmv.21016
53. Chatterjee NK, Hou J, Dockstader P, Charbonneau T. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J Med Virol (1992) 38:124-31. doi:10.1002/jmv.1890380210
54. Jaïdane H, Gharbi J, Lobert PE, Lucas B, Hiar R, M'Hadheb MB, et al. Prolonged viral RNA detection in blood and lymphoid tissues from coxsackievirus B4-E2 orally-inoculated mice. Microbiol Immunol (2006) 50:971-4. doi:10.1111/j.1348-0421.2006.tb03874.x
55. Jaïdane H, Caloone D, Lobert PE, Sané F, Dardenne O, Naquet P, et al. Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor. J Virol (2012) 86:11151-62. doi:10.1128/JVI.00726-12
56. Zinkernagel RM. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med (2001) 345:1331-5. doi:10.1056/NEJMra012493
57. Viskari HR, Roivainen M, Reunanen A, Pitkäniemi J, Sadeharju K, Koskela P, et al. Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes (2002) 51:2568-71. doi:10.2337/diabetes.51.8.2568
58. Elfving M, Svensson J, Oikarinen S, Jonsson B, Olofsson P, Sundkvist G, et al. Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age. Exp Diabetes Res (2008) 2008:271958. doi:10.1155/2008/271958
59. Bopegamage S, Precechtelova J, Marosova L, Stipalova D, Sojka M, Borsanyiova M, et al. Outcome of challenge with coxsackievirus B4 in young mice after maternal infection with the same virus during gestation. FEMS Immunol Med Microbiol (2012) 64:184-90. doi:10.1111/j.1574-695X.2011.00886.x
60. Gale EAM, Atkinson M. A piece of nucleic acid surrounded by controversy: coxsackievirus and the cause of type 1 diabetes. Diabet Med (2004) 21:503-6. doi:10.1111/j.1464-5491.2004.01181.x
61. Yewdell JY, Hill AB. Viral interference with antigen presentation. Nat Immunol (2002) 3:1019-25. doi:10.1038/ni1102-1019
62. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care (2000) 23:1516-26. doi:10.2337/diacare.23.10.1516